Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014, Article ID 484926, 10 pages
http://dx.doi.org/10.1155/2014/484926
Research Article

System Analysis of LWDH Related Genes Based on Text Mining in Biological Networks

1College of Life Sciences, Northwest A&F University, Yangling, Shaanxi 712100, China
2College of Pharmacy, Nankai University, Tianjin 300071, China
3College of Bioinformatics Science and Technology, Harbin Medical University, Harbin 150081, China
4Department of Statistics, Rice University, 6100 Main Street, Houston, TX 77005, USA
5Department of Nutrition and Food Hygiene, School of Public Health, Harbin Medical University, Harbin 150081, China
6College of Life Science, Anhui Agricultural University, Hefei 230036, China
7Genome Analysis Laboratory, Tianjin Institute of Industrial Biotechnology, Chinese Academy of Sciences, Tianjin 300308, China

Received 15 May 2014; Revised 2 July 2014; Accepted 3 July 2014; Published 27 August 2014

Academic Editor: Tatsuya Akutsu

Copyright © 2014 Mingzhi Liao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Li, Z. Q. Zhang, L. J. Wu, X. G. Zhang, Y. D. Li, and Y. Y. Wang, “Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network,” IET Systems Biology, vol. 1, no. 1, pp. 51–60, 2007. View at Publisher · View at Google Scholar · View at Scopus
  2. J. Qiu, “China plans to modernize traditional medicine,” Nature, vol. 446, no. 7136, pp. 590–591, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Liang, L. Li, M. Wang et al., “Molecular network and chemical fragment-based characteristics of medicinal herbs with cold and hot properties from Chinese medicine,” Journal of Ethnopharmacology, vol. 148, no. 3, pp. 770–779, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Li, B. Zhang, D. Jiang, Y. Wei, and N. Zhang, “Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae,” BMC Bioinformatics, vol. 11, supplement 11, article S6, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Li, B. Zhang, and N. Zhang, “Network target for screening synergistic drug combinations with application to traditional Chinese medicine,” BMC Systems Biology, vol. 5, supplement 1, article S10, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. S. Zhao and S. Li, “Network-based relating pharmacological and genomic spaces for drug target identification,” PLoS ONE, vol. 5, no. 7, Article ID e11764, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. X. Liang, H. Li, and S. Li, “A novel network pharmacology approach to analyse traditional herbal formulae: the Liu-Wei-Di-Huang pill as a case study,” Molecular BioSystems, vol. 10, no. 5, pp. 1014–1022, 2014. View at Google Scholar
  8. H.-C. Tang and C. Y.-C. Chen, “In silico design for adenosine monophosphate-activated protein kinase agonist from traditional chinese medicine for treatment of metabolic syndromes,” Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID 928589, 16 pages, 2014. View at Publisher · View at Google Scholar
  9. H. J. Huang, Y. R. Jian, and C. Y. Chen, “Traditional Chinese medicine application in HIV: an in silico study,” Journal of Biomolecular Structure and Dynamics, vol. 32, no. 1, pp. 1–12, 2014. View at Google Scholar
  10. Y.-C. Fang, H.-C. Huang, H.-H. Chen, and H.-F. Juan, “TCMGeneDIT: a database for associated traditional Chinese medicine, gene and disease information using text mining,” BMC Complementary and Alternative Medicine, vol. 8, no. 1, article 58, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Y.-C. Chen, “TCM Database Taiwan: the world's largest traditional Chinese medicine database for drug screening in silico,” PLoS ONE, vol. 6, no. 1, Article ID e15939, 2011. View at Google Scholar
  12. K. Chang, T. Tsai, K. Chen et al., “iSMART: an integrated cloud computing web server for traditional Chinese medicine for online virtual screening, de novo evolution and drug design,” Journal of Biomolecular Structure and Dynamics, vol. 29, no. 1, pp. 243–250, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. T. Tsai, K. Chang, and C. Y. Chen, “IScreen: World's first cloud-computing web server for virtual screening and de novo drug design based on TCM database@Taiwan,” Journal of Computer-Aided Molecular Design, vol. 25, no. 6, pp. 525–531, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. W. Tao, X. Xu, X. Wang et al., “Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease,” Journal of Ethnopharmacology, vol. 145, no. 1, pp. 1–10, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. W. Zhou and Y. Wang, “A network-based analysis of the types of coronary artery disease from traditional Chinese medicine perspective: potential for therapeutics and drug discovery,” Journal of Ethnopharmacology, vol. 151, no. 1, pp. 66–77, 2014. View at Publisher · View at Google Scholar
  16. C. T. Keith, A. A. Borisy, and B. R. Stockwell, “Multicomponent therapeutics for networked systems,” Nature Reviews Drug Discovery, vol. 4, no. 1, pp. 71–78, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. A. L. Hopkins, “Network pharmacology: the next paradigm in drug discovery,” Nature Chemical Biology, vol. 4, no. 11, pp. 682–690, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. A. L. Hopkins, “Network pharmacology,” Nature Biotechnology, vol. 25, no. 10, pp. 1110–1111, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M. A. Yıldırım, K.-I. Goh, M. E. Cusick, A.-L. Barabási, and M. Vidal, “Drug—target network,” Nature Biotechnology, vol. 25, no. 10, pp. 1119–1126, 2007. View at Google Scholar
  20. M. Zhu, L. Gao, X. Li et al., “The analysis of the drug-targets based on the topological properties in the human protein-protein interaction network,” Journal of Drug Targeting, vol. 17, no. 7, pp. 524–532, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. C. Wang, W. Jiang, W. Li et al., “Topological properties of the drug targets regulated by microRNA in human protein-protein interaction network,” Journal of Drug Targeting, vol. 19, no. 5, pp. 354–364, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. L. Yang, W. Jizhe, W. Huiping, L. Yingli, Z. Yongchun, and W. Jiang, “Analysis and identification of toxin targets by topological properties in protein-protein interaction network,” Journal of Theoretical Biology, vol. 349, pp. 82–91, 2014. View at Publisher · View at Google Scholar
  23. M. Oshima, R. Torii, S. Tokuda, S. Yamada, and A. Koizumi, “Patient-specific modeling and multi-scale blood simulation for computational hemodynamic study on the human cerebrovascular system,” Current Pharmaceutical Biotechnology, vol. 13, no. 11, pp. 2153–2165, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Alan, “How can network-pharmacology contribute to antiepileptic drug development?” Molecular & Cellular Epilepsy, vol. 1, no. 1, 2014. View at Google Scholar
  25. H.-P. Zhang, J.-B. Pan, C. Zhang, N. Ji, H. Wang, and Z.-L. Ji, “Network understanding of herb medicine via rapid identification of ingredient-target interactions,” Scientific Reports, vol. 4, article 3719, 2014. View at Publisher · View at Google Scholar
  26. S. Wasserman, Social Network Analysis: Methods and Applications, vol. 8, Cambridge University Press, Cambridge, Mass, USA, 1994.
  27. L. Tanabe and W. J. Wilbur, “Tagging gene and protein names in biomedical text,” Bioinformatics, vol. 18, no. 8, pp. 1124–1132, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Chatr-Aryamontri, B.-J. Breitkreutz, S. Heinicke et al., “The BioGRID interaction database: 2013 update,” Nucleic Acids Research, vol. 41, no. D1, pp. D816–D823, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. T. S. Keshava Prasad, R. Goel, K. Kandasamy et al., “Human Protein Reference Database—2009 update,” Nucleic Acids Research, vol. 37, supplement 1, pp. D767–D772, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. L. C. Freeman, “Centered graphs and the structure of ego networks,” Mathematical Social Sciences, vol. 3, no. 3, pp. 291–304, 1982. View at Publisher · View at Google Scholar · View at Zentralblatt MATH · View at MathSciNet · View at Scopus
  31. D. J. Watts and S. H. Strogatz, “Collective dynamics of “small-world”' networks,” Nature, vol. 393, no. 6684, pp. 440–442, 1998. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Saito, M. E. Smoot, K. Ono et al., “A travel guide to Cytoscape plugins,” Nature Methods, vol. 9, no. 11, pp. 1069–1076, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Assenov, F. Ramírez, S. E. Schelhorn, T. Lengauer, and M. Albrecht, “Computing topological parameters of biological networks,” Bioinformatics, vol. 24, no. 2, pp. 282–284, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. C. Knox, V. Law, T. Jewison et al., “DrugBank 3.0: a comprehensive resource for “Omics” research on drugs,” Nucleic Acids Research, vol. 39, supplement 1, pp. D1035–D1041, 2011. View at Publisher · View at Google Scholar · View at Scopus
  35. V. Matys, O. V. Kel-Margoulis, E. Fricke et al., “TRANSFAC and its module TRANSCompel: transcriptional gene regulation in eukaryotes,” Nucleic Acids Research, vol. 34, supplement 1, pp. D108–110, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Vergoulis, I. S. Vlachos, P. Alexiou et al., “TarBase 6.0: capturing the exponential growth of miRNA targets with experimental support,” Nucleic Acids Research, vol. 40, no. 1, pp. D222–D229, 2012. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. T. Tseng, F. R. Chang, and Y. C. Lo, “The Chinese herbal formula Liuwei dihuang protects dopaminergic neurons against Parkinson's toxin through enhancing antioxidative defense and preventing apoptotic death,” Phytomedicine, vol. 21, no. 5, pp. 724–733, 2014. View at Publisher · View at Google Scholar
  38. A. Hamosh, A. F. Scott, J. S. Amberger, C. A. Bocchini, and V. A. McKusick, “Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders,” Nucleic Acids Research, vol. 33, no. supplement 1, pp. D514–D517, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. P. Y. Ma, Z. Y. Fu, Y. L. Su et al., “Modification of physicochemical and medicinal characterization of Liuwei Dihuang particles by ultrafine grinding,” Powder Technology, vol. 191, no. 1-2, pp. 194–199, 2009. View at Publisher · View at Google Scholar · View at Scopus
  40. N. Zhang and X. Wang, “Determination of constituents of Liuwei Dihuang Wan migrating to blood,” Traditional Chinese Drug Research And Clinical Pharmacology, vol. 15, no. 3, pp. 174–176, 2003. View at Google Scholar
  41. Y. Liu, M. Cheng, L. Wang, N. Zhao, H. Xiao, and Z. Wang, “Functional analysis of cultured neural cells for evaluating cold/cool- and hot/warm-natured Chinese herbs,” The American Journal of Chinese Medicine, vol. 36, no. 4, pp. 771–781, 2008. View at Publisher · View at Google Scholar · View at Scopus